Lipids

Lipid-based excipients from IOI Oleo help to improve the bioavailability of poorly soluble active ingredients. The majority of new active...

Abstract Cannabidiol (CBD) exhibits poor oral bioavailability (approximately 6%) due to low solubility and excessive first-pass metabolism, limiting its therapeutic...

See the poster by RCPE and IOI Oleo: Lipids: Enormous potential impaired with tough challenges This work investigates the solid-state...

Abstract Background: The therapeutic potential of many natural products, including curcumin (CUR), betulinic acid (BA), and oleanolic acid (OA), is limited...

IOI Oleo launched a new family of functional, lipid-based excipients, the polyglycerol esters at CPhI 2025. As the CPhI 2026...

See the poster presented by Gattefossé at the Controlled Release Society congress in Lisbon, Portugal. Introduction Figure 1. Anle 138b...

LipoGalen™ 144 – The innovative new base for ovules and suppositories The innovative new base for ovules and suppositories Novelty...

Abstract Drug delivery via aerosolization is a non-invasive and ideal method for targeting the pulmonary system, achieving localized effect. This study aims...

Abstract Introduction Globally, lung cancer is one of the most common types of cancer. Despite advances in treatment, the clinical...

The Oral Drug Delivery Landscape As drug discovery pushes into new therapeutic frontiers, the task of developing effective, patient-friendly oral...